Treatment.Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Treatment.com International Inc. (TRUE) operate in?
Treatment.com International Inc. belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Treatment.com International Inc. (TRUE) current stock price?
As of the latest data, Treatment.com International Inc. stock price is CA$0.89, with a previous close of CA$0.89.
What is Treatment.com International Inc. (TRUE) current market capitalization?
Treatment.com International Inc. market cap is approximately 67.20 million.
What is Treatment.com International Inc. (TRUE) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.19.
Does Treatment.com International Inc. (TRUE) pay dividends?
No. Treatment.com International Inc. does not pay a dividend.
What is Treatment.com International Inc. (TRUE) beta (volatility) score?
Treatment.com International Inc. has a beta of -0.430, indicating lower volatility than the overall market.
